| Product Code: ETC13131243 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Granisetron Market was valued at USD 0.38 Billion in 2024 and is expected to reach USD 0.6 Billion by 2031, growing at a compound annual growth rate of 6.80% during the forecast period (2025-2031).
The Global Granisetron Market is experiencing steady growth driven by factors such as the increasing prevalence of chemotherapy-induced nausea and vomiting (CINV) among cancer patients, and the rising demand for effective antiemetic drugs. Granisetron, a 5-HT3 receptor antagonist, is widely used to prevent and treat CINV, making it a key player in the oncology supportive care market. The market is also benefiting from the development of extended-release formulations and the availability of generic versions, which are more cost-effective options for healthcare providers and patients. North America and Europe dominate the market, but Asia Pacific is expected to witness significant growth due to the increasing cancer burden in the region. Key market players include Cipla, Sandoz, Mylan, and Teva Pharmaceuticals, among others.
The global granisetron market is experiencing steady growth due to the increasing prevalence of chemotherapy-induced nausea and vomiting (CINV) among cancer patients. The market is also benefiting from the rising adoption of granisetron as an effective antiemetic medication. Additionally, the expanding applications of granisetron beyond CINV, such as in the treatment of postoperative nausea and vomiting (PONV) and radiation-induced nausea and vomiting (RINV), are creating new opportunities for market growth. With advancements in drug delivery technologies and the introduction of generic versions of granisetron, the market is becoming more competitive, driving down prices and increasing accessibility. As healthcare systems worldwide focus on improving supportive care for cancer patients, the global granisetron market is poised for continued expansion.
The Global Granisetron Market faces several challenges, including the presence of generic alternatives that can lead to pricing pressures and reduced profit margins for companies manufacturing the drug. Additionally, regulatory hurdles and stringent approval processes in various regions can hinder market growth and expansion opportunities. The competitive landscape with multiple players offering similar products also poses a challenge in terms of market share and differentiation. Furthermore, the potential side effects and safety concerns associated with granisetron usage could impact patient acceptance and adoption of the drug, leading to slower market growth. Overall, navigating these challenges and effectively addressing them will be crucial for companies operating in the Global Granisetron Market to maintain a competitive edge and drive sustainable growth.
The Global Granisetron Market is primarily driven by the increasing prevalence of cancer and chemotherapy treatments worldwide, leading to a higher demand for antiemetic drugs like granisetron to manage chemotherapy-induced nausea and vomiting (CINV). Additionally, the growing adoption of granisetron in the treatment of post-operative nausea and vomiting (PONV) further propels market growth. The expanding geriatric population, who are more susceptible to cancer and related treatments, also contributes to the market`s growth. Moreover, advancements in drug delivery technologies, such as extended-release formulations and transdermal patches, are enhancing the efficacy and convenience of granisetron, driving its market penetration. The rising awareness about the importance of managing CINV and PONV effectively among healthcare professionals and patients is further fueling the market expansion.
Government policies related to the Global Granisetron Market vary by country, with regulations primarily focused on licensing, manufacturing standards, pricing, and distribution. In the United States, the Food and Drug Administration (FDA) oversees the approval and regulation of granisetron, ensuring its safety and efficacy for patients. In the European Union, the European Medicines Agency (EMA) plays a similar role in regulating the market. Pricing policies, such as reimbursement or pricing controls, can impact market access and affordability for patients. Additionally, policies related to intellectual property rights and patent protection can influence competition and market dynamics. Overall, government policies in different regions aim to balance innovation, patient safety, and access to granisetron and other pharmaceutical products.
The Global Granisetron Market is expected to see steady growth in the coming years, driven by the rising prevalence of chemotherapy-induced nausea and vomiting (CINV) among cancer patients. The increasing adoption of granisetron as an effective antiemetic medication, along with the development of new formulations and delivery methods, will further propel market expansion. Additionally, the growing focus on improving patient outcomes and quality of life will drive the demand for granisetron in both developed and emerging markets. However, factors such as patent expirations, generic competition, and pricing pressures may pose challenges to market growth. Overall, the Global Granisetron Market is anticipated to witness sustained growth due to the expanding patient population and the continuous innovation in the field of supportive cancer care.
In the global granisetron market, North America and Europe are expected to hold significant market shares due to the high prevalence of chemotherapy-induced nausea and vomiting (CINV) in these regions, coupled with well-established healthcare infrastructure. Asia Pacific is anticipated to witness the fastest growth attributed to increasing healthcare expenditure, rising awareness about CINV management, and the growing availability of generic granisetron formulations. In the Middle East and Africa region, the market is likely to experience steady growth driven by improving healthcare facilities and increasing investments in cancer care. The Latin America market is projected to show moderate growth, supported by the rising incidence of cancer and government initiatives to improve cancer treatment access. Overall, the global granisetron market is poised for expansion across all regions due to the increasing burden of cancer worldwide.
Global Granisetron Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Granisetron Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Granisetron Market Revenues & Volume, 2021 & 2031F |
3.3 Global Granisetron Market - Industry Life Cycle |
3.4 Global Granisetron Market - Porter's Five Forces |
3.5 Global Granisetron Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Granisetron Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Granisetron Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Granisetron Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Granisetron Market Trends |
6 Global Granisetron Market, 2021 - 2031 |
6.1 Global Granisetron Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Granisetron Market, Revenues & Volume, By Transdermal, 2021 - 2031 |
6.1.3 Global Granisetron Market, Revenues & Volume, By Injection, 2021 - 2031 |
6.1.4 Global Granisetron Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2 Global Granisetron Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Granisetron Market, Revenues & Volume, By Chemotherapy, 2021 - 2031 |
6.2.3 Global Granisetron Market, Revenues & Volume, By Post Operative, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Granisetron Market, Overview & Analysis |
7.1 North America Granisetron Market Revenues & Volume, 2021 - 2031 |
7.2 North America Granisetron Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Granisetron Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Granisetron Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Granisetron Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Granisetron Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Granisetron Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Granisetron Market, Overview & Analysis |
8.1 Latin America (LATAM) Granisetron Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Granisetron Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Granisetron Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Granisetron Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Granisetron Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Granisetron Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Granisetron Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Granisetron Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Granisetron Market, Overview & Analysis |
9.1 Asia Granisetron Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Granisetron Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Granisetron Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Granisetron Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Granisetron Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Granisetron Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Granisetron Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Granisetron Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Granisetron Market, Overview & Analysis |
10.1 Africa Granisetron Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Granisetron Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Granisetron Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Granisetron Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Granisetron Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Granisetron Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Granisetron Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Granisetron Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Granisetron Market, Overview & Analysis |
11.1 Europe Granisetron Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Granisetron Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Granisetron Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Granisetron Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Granisetron Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Granisetron Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Granisetron Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Granisetron Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Granisetron Market, Overview & Analysis |
12.1 Middle East Granisetron Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Granisetron Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Granisetron Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Granisetron Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Granisetron Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Granisetron Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Granisetron Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Granisetron Market Key Performance Indicators |
14 Global Granisetron Market - Export/Import By Countries Assessment |
15 Global Granisetron Market - Opportunity Assessment |
15.1 Global Granisetron Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Granisetron Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Granisetron Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Granisetron Market - Competitive Landscape |
16.1 Global Granisetron Market Revenue Share, By Companies, 2024 |
16.2 Global Granisetron Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |